Skip to main content
OpenTrials
Completed

NCT Number: NCT01249586

E-learning: Teaching of Blindness Prevention

E-learning material increases the student knowledge level before the traditional class of blindness prevention and help to fix this information a short period (one month) after the class.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Teaching Technique

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Clinics Hospital of the State University of Campinas

Campinas, São Paulo, 6111, Brazil

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • being a medical student matriculated in the course of ophthalmology. This course is taught to fourth-year students at State University of Campinas.

Exclusion criteria

-

Treatment and study plan

e-learning

Other

A traditional class of blindness prevention plus an additional e-learning material. The e-learning material included a PDF article about blindness prevention. This material was e-mailed one week before the traditional class.

Primary outcomes

  1. Immediate pretest score

Secondary outcomes

  1. One-month posttest score

  2. Immediate posttest score.

Sponsors and collaborators

Lead sponsor

Clinica Oftamologica Zona Sul

Other

Registry information

Official study title

E-learning as a Complement to Traditional Teaching of Blindness Prevention

Acronym: ELBPS

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Nov 30, 2010
Registry last updated
Nov 30, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.